Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Triglycerides, or triacylglycerols, are the primary form of energy storage in humans and a major dietary lipid component, consisting of a glycerol backbone esterified with three fatty acids (Source: PubChem, StatPearls). In enteral formulas, they serve as a critical caloric source for patients unable to consume food orally, often provided in varying ratios of Medium-Chain Triglycerides (MCTs) and Long-Chain Triglycerides (LCTs) to optimize absorption (Source: NIH, Mayo Clinic). MCTs are absorbed directly into the portal circulation, making them useful for patients with malabsorption, while LCTs require bile salts and lymphatic transport (Source: StatPearls). Although triglycerides are nutrients rather than traditional therapeutic targets like receptors, their metabolism is a key focus of drug therapy. For instance, the drug orlistat inhibits gastric and pancreatic lipases to prevent the breakdown and absorption of triglycerides for the treatment of obesity (Source: FDA, PubChem). Additionally, medications such as fibrates and omega-3 fatty acids are used to lower elevated plasma triglyceride levels, thereby reducing the risk of cardiovascular disease and acute pancreatitis (Source: Mayo Clinic, StatPearls).
Triglycerides are dietary nutrients and metabolic substrates rather than therapeutic targets. Drugs affecting them typically act by inhibiting digestive enzymes like pancreatic lipase (e.g., orlistat) or by modulating transcriptional regulators of lipid metabolism like PPAR-alpha (e.g., fibrates) to alter systemic levels (Source: PubChem, StatPearls).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Triglyceride (TG) (TG).